Acute myeloid leukemia with minimal differentiation: A multiple parameter study

American Journal of Clinical Pathology

Volumn 109, Issue 1, 1998, Pages 32-38

  Cohen, Patti L ^a   Hoyer, James D ^a   Kurtin, Paul J ^a   Dewald, Gordon W ^a   Hanson, Curtis A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Acute myeloid leukemia; Acute myeloid leukemia with minimal differentiation; Immunopheno typing; Stem cell leukemia

Indexed keywords

1 NAPHTHYL BUTYRATE ESTERASE; ANTINEOPLASTIC AGENT; CD33 ANTIGEN; CD34 ANTIGEN; CELL ANTIGEN; DNA NUCLEOTIDYLEXOTRANSFERASE; ESTERASE; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE; MYELOPEROXIDASE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG RESISTANCE; FEMALE; HUMAN; KARYOTYPING; MALE; MONOSOMY 7; MYELODYSPLASIA; PARAMETER; PRIORITY JOURNAL; TRISOMY 13; TUMOR DIFFERENTIATION;

EID: 0031973660     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/109.1.32     Document Type: Article

References (29)

1. Lee E, Pollak A, Leavitt R, Testa J, Schiffer C. Minimally differentiated acute nonlymphocytic leukemia: a distinct entity. Blood. 1987;70:1400-1406.
2. Cheson B, Cassileth P, Head D, et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol. 1990;8:813-819.
3. Bennett JM, Catovsky D, Daniel M-T, et al. Proposal for the recognition of minimally differentiated acute myeloid leukemia (AML-M0). Br J Haematol. 1991;78:325-329.
4. Yam LT, Li CY, Crosby WH. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol. 1971;55:283-290.
5. Cartun RW, Pedersen CA. An immunocytochemical technique offering increased sensitivity and lowered cost with a streptavidin-horseradish peroxidase conjugate. J Histotechnol. 1989;12:273-277.
6. Borowitz MJ, Guenther KL, Shults KE, Stelzer GT. Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol. 1993;100:534-540.
7. Mitelman F. ICSN 1995: An international system for human cytogenetic nomenclature (1995). ICSN Meeting. Memphis, Tennesee, 1994.
8. Praxedes MK, De Oliveira LZ, Pereira WDV, Quintana IZ, Tabak DG, De Oliveira MSP. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukemia. Leukemia Lymphoma. 1994;12:233-239.
9. Venditti A, Del Poeta G, Stasi R, et al. Minimally differentiated acute myeloid leukaemia (AML-M0): cytochemical, immunophenotypic, and cytogenetic analysis of 19 cases. Br J Haematol. 1994;88:784-793.
10. Venditti A, Del Poeta G, Buccisano F, et al. Minimally differentiated acute myeloid leukaemia (AML-M0). Comparison of 25 cases with other French-American-British subtypes. Blood. 1997;89:621-629.
11. Cuneo A, Ferrant A, Michaux JL, et al. Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findings. Blood. 1995;12:3688-3694.
12. Traweek ST, Liu J, Braziel RM, Johnson RM, Brynes RK. Detection of myeloperoxidase gene expression in minimally differentiated acute myelogenous leukemia (AML-M0) using in situ hybridization. Diagn Mol Pathol. 1995;4:212-219.
13. Catovsky D, Matutes E, Buccheri V, et al. A classification of acute leukemia for the 1990s. Ann Hematol. 1991;62:16-21.
14. Traweek ST. Immunophenotypic analysis of acute leukemia. Am J Clin Pathol. 1993;99:504-512.
15. Arber DA, Jenkins KA. Paraffin section immunophenotyping of acute leukemias in bone marrow specimens. Am J Clin Pathol. 1996;106:462-168.
16. Hoyer JD, Kurtin PJ, Hanson CA. Comparison of cytochemical and immunologic methods for detecting myeloperoxidase (MPO) in acute leukemias. Mod Pathol. 1996;9:113. Abstract.
17. Ball ED, Davis RB, Griffin JD, et al. Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood. 1991;77:2242-2250.
18. Hanson CA, Abaza M, Sheldon S, Ross CW, Schnitzer B, Stoolman LM. Acute biphenotypic leukaemia: immunophenotypic and cytogenetic analysis. Br J Haematol. 1993;84:49-60.
19. Mason DY, Stein H, Gerdes J, et al. Value of monoclonal anti-CD22 (p135) antibodies for the detection of normal and neoplastic B lymphoid cells. Blood. 1987;69:836-840.
20. Boué DR, LeBien TW. Expression and structure of CD22 in acute leukemia. Blood. 1988;71:1480-1486.
21. Howard MR, Thomas L, Reid MM. Variable detection of myeloid antigens in childhood acute lymphoblastic leukaemia. J Clin Pathol. 1994;47:1006-1009.
22. Yokose N, Ogata K, Ito T, et al. Chemotherapy for minimally differentiated acute myeloid leukemia (AML-M0). A report on five cases and review of the literature. Am J Hematol. 1993;66:67-70.
23. Sempere A, Jarque I, Guinot M, et al. Acute myeloblastic leukemia with minimal myeloid differentiation (FAB AML-M0): a study of eleven cases. Leuk Lymphoma. 1993;12:103-108.
24. Stasi R, Del Poeta G, Venditti A, et al. Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0). Blood. 1994;83:1619-1625.
25. Segeren CM, de Jong-Gerrits GCMM, van't Veer MB. AML-M0: clinical entity or waste basket for immature blastic leukemias? A description of 14 patients. Ann Hematol. 1995;70:297-300.
26. Venditti A, Del Poeta G, Stasi R, et al. Biological profile of 23 cases of minimally differentiated acute myeloid leukemia (AML-M0) and its clinical implications. Blood. 1996;87:418-420. Letter.
27. Drexler HG, Sperling C, Ludwig W-D. Terminal deoxynucleotidyltransferase (TdT) expression in acute myeloid leukemia. Leukemia. 1993;7:1142-1150.
28. Alurkar SS, Chopra HK, Nair CN, et al. Minimally differentiated acute myeloid leukemia: a morphologic, cytochemical and ultrastructural study. Tumori. 1992;78:185-189.
29. Baudard M, Marie JP, Cadiou M, Viguié, Zittoun R. Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patients. Br J Haematol. 1994;86:82-91.